Latest AMD Stories
Collaboration benefits professional users by bringing together legendary Matrox graphics board design expertise and outstanding AMD GPU performance. MONTREAL
Over Three-Quarters of Physicians View Ophthotech's Fovista as an Emerging Therapy with High Potential Value for Wet AMD, According to Findings from Decision Resources Group BURLINGTON, Mass.,
Surpasses Rival Offerings with Support for 25x More Games, Extends Experience to Include Seamless Uploading, Sharing and Community MOUNTAIN VIEW, Calif., July 28, 2014 /PRNewswire/
Global Graphics Add-in Board Market 2014-2018, a new research report added to Sandlerresearch.org store. Dallas, Texas (PRWEB) July 09, 2014 Vendors
First clinical trial of integrated approach underlines need for inclusion of behavior activation therapy in low vision rehabilitation SAN FRANCISCO, July 9, 2014 /PRNewswire-USNewswire/ --
Diopsys® NOVA-ERG provides a way to discriminate between AMD and healthy eyes. Pine Brook, NJ (PRWEB) July 01, 2014 In a controlled clinical study,
SOPHIA ANTIPOLIS, France, and SAN DIEGO, June 19, 2014 /PRNewswire/ -- Nicox S.A. (NYSE Euronext Paris: COX), the international ophthalmic company, and Sequenom, Inc.
Ophthalmologist Michael Tracy, MD of Carlsbad Eye Care describes new findings on potential eye dangers. San Diego, CA (PRWEB) June 12, 2014
TARRYTOWN, N.Y., June 11, 2014 /PRNewswire/ -- Regeneron Pharmaceuticals, Inc.
- The act of sweetening by admixture of some saccharine substance.